Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution

Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution

Abstract Background Angiosarcoma is an uncommon endothelial malignancy and a highly aggressive soft tissue sarcoma. Due to its infiltrative nature, successful management of localized angiosarcoma is often challenging. Systemic chemotherapy is used in the metastatic setting and occasionally in patien...

Full description

Bibliographic Details
Main Authors: Vaia Florou, Andrew E. Rosenberg, Eric Wieder, Krishna V. Komanduri, Despina Kolonias, Mohamed Uduman, John C. Castle, Jennifer S. Buell, Jonathan C. Trent, Breelyn A. Wilky
Format: Article
Language:English
Published: BMJ Publishing Group 2019-08-01
Series:Journal for ImmunoTherapy of Cancer
Subjects:
Angiosarcoma
Checkpoint inhibitors
CTLA-4 antibody
Fusions
Tumor mutation burden
Online Access:http://link.springer.com/article/10.1186/s40425-019-0689-7

Internet

http://link.springer.com/article/10.1186/s40425-019-0689-7

Similar Items